Bionano genomics granted 180-day extension by nasdaq to regain compliance with bid price rule

San diego, dec. 30, 2020 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo), announced today that nasdaq has granted the company an additional 180-day compliance period, or until june 28, 2021, to regain compliance with nasdaq's minimum $1.00 closing bid price per share requirement.
BNGO Ratings Summary
BNGO Quant Ranking